Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics.
Triosephosphate isomerase (TPI) deficiency is a poorly understood disease characterized by hemolytic anemia, cardiomyopathy, neurologic dysfunction, and early death. TPI deficiency is one of a group of diseases known as glycolytic enzymopathies, but is unique for its severe patient neuropathology an...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-03-01
|
| Series: | PLoS Genetics |
| Online Access: | http://europepmc.org/articles/PMC4816394?pdf=render |
| _version_ | 1819094182906560512 |
|---|---|
| author | Bartholomew P Roland Alison M Zeccola Samantha B Larsen Christopher G Amrich Aaron D Talsma Kimberly A Stuchul Annie Heroux Edwin S Levitan Andrew P VanDemark Michael J Palladino |
| author_facet | Bartholomew P Roland Alison M Zeccola Samantha B Larsen Christopher G Amrich Aaron D Talsma Kimberly A Stuchul Annie Heroux Edwin S Levitan Andrew P VanDemark Michael J Palladino |
| author_sort | Bartholomew P Roland |
| collection | DOAJ |
| description | Triosephosphate isomerase (TPI) deficiency is a poorly understood disease characterized by hemolytic anemia, cardiomyopathy, neurologic dysfunction, and early death. TPI deficiency is one of a group of diseases known as glycolytic enzymopathies, but is unique for its severe patient neuropathology and early mortality. The disease is caused by missense mutations and dysfunction in the glycolytic enzyme, TPI. Previous studies have detailed structural and catalytic changes elicited by disease-associated TPI substitutions, and samples of patient erythrocytes have yielded insight into patient hemolytic anemia; however, the neuropathophysiology of this disease remains a mystery. This study combines structural, biochemical, and genetic approaches to demonstrate that perturbations of the TPI dimer interface are sufficient to elicit TPI deficiency neuropathogenesis. The present study demonstrates that neurologic dysfunction resulting from TPI deficiency is characterized by synaptic vesicle dysfunction, and can be attenuated with catalytically inactive TPI. Collectively, our findings are the first to identify, to our knowledge, a functional synaptic defect in TPI deficiency derived from molecular changes in the TPI dimer interface. |
| first_indexed | 2024-12-21T23:23:21Z |
| format | Article |
| id | doaj.art-b75cd7b9bdc3464da04a9f6e4c95a120 |
| institution | Directory Open Access Journal |
| issn | 1553-7390 1553-7404 |
| language | English |
| last_indexed | 2024-12-21T23:23:21Z |
| publishDate | 2016-03-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Genetics |
| spelling | doaj.art-b75cd7b9bdc3464da04a9f6e4c95a1202022-12-21T18:46:45ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042016-03-01123e100594110.1371/journal.pgen.1005941Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics.Bartholomew P RolandAlison M ZeccolaSamantha B LarsenChristopher G AmrichAaron D TalsmaKimberly A StuchulAnnie HerouxEdwin S LevitanAndrew P VanDemarkMichael J PalladinoTriosephosphate isomerase (TPI) deficiency is a poorly understood disease characterized by hemolytic anemia, cardiomyopathy, neurologic dysfunction, and early death. TPI deficiency is one of a group of diseases known as glycolytic enzymopathies, but is unique for its severe patient neuropathology and early mortality. The disease is caused by missense mutations and dysfunction in the glycolytic enzyme, TPI. Previous studies have detailed structural and catalytic changes elicited by disease-associated TPI substitutions, and samples of patient erythrocytes have yielded insight into patient hemolytic anemia; however, the neuropathophysiology of this disease remains a mystery. This study combines structural, biochemical, and genetic approaches to demonstrate that perturbations of the TPI dimer interface are sufficient to elicit TPI deficiency neuropathogenesis. The present study demonstrates that neurologic dysfunction resulting from TPI deficiency is characterized by synaptic vesicle dysfunction, and can be attenuated with catalytically inactive TPI. Collectively, our findings are the first to identify, to our knowledge, a functional synaptic defect in TPI deficiency derived from molecular changes in the TPI dimer interface.http://europepmc.org/articles/PMC4816394?pdf=render |
| spellingShingle | Bartholomew P Roland Alison M Zeccola Samantha B Larsen Christopher G Amrich Aaron D Talsma Kimberly A Stuchul Annie Heroux Edwin S Levitan Andrew P VanDemark Michael J Palladino Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. PLoS Genetics |
| title | Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. |
| title_full | Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. |
| title_fullStr | Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. |
| title_full_unstemmed | Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. |
| title_short | Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. |
| title_sort | structural and genetic studies demonstrate neurologic dysfunction in triosephosphate isomerase deficiency is associated with impaired synaptic vesicle dynamics |
| url | http://europepmc.org/articles/PMC4816394?pdf=render |
| work_keys_str_mv | AT bartholomewproland structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT alisonmzeccola structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT samanthablarsen structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT christophergamrich structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT aarondtalsma structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT kimberlyastuchul structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT annieheroux structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT edwinslevitan structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT andrewpvandemark structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics AT michaeljpalladino structuralandgeneticstudiesdemonstrateneurologicdysfunctionintriosephosphateisomerasedeficiencyisassociatedwithimpairedsynapticvesicledynamics |